HISP India has developed a robust digital Antimicrobial Resistance (AMR) Surveillance System using the free and open-source DHIS2 platform. This system represents a major advancement in infectious disease control and healthcare data management. In Varanasi, where healthcare facilities are primarily dedicated to cancer research, the system has been customized to meet specific institutional needs.

The AMR surveillance system empowers microbiology lab technicians to enter patient data efficiently while enabling real-time analysis of susceptibility percentages and antibiograms through interactive dashboards. It also categorizes resistance patterns and genes across various organism groups, classifying them into Multi-Drug Resistant (MDR), Extensively Drug Resistant (XDR), and Pan-Drug Resistant (PDR) categories.

Key features include:

• Syndrome-based and sample-type analysis: Data is structured around different syndromes and sample types (diagnostic vs. surveillance), providing a comprehensive view of resistance trends.
• Advanced filtering options: Users can analyze data based on location, department, and sample type, enhancing usability for epidemiological insights.
• Curated reports: These reports help correlate risk factors with specific syndromes, aiding decision-making for infection control strategies.

To enhance interoperability, Varanasi’s healthcare facilities, which operate proprietary software systems, have successfully integrated their existing patient data repositories with the AMR surveillance system. This integration enables automated data import, ensuring seamless aggregation of clinical events. The system facilitates in-depth analysis and visualization through interactive dashboards, featuring comprehensive data tables and visual charts.

By strengthening microbiology labs and improving data-driven decision-making, HISP India’s AMR surveillance system contributes to enhanced patient care, informed antibiotic stewardship policies, and improved responses to antimicrobial resistance trends.